SELENBP1 antibody (PE)

Catalog No. ABIN2179105

This Rabbit Polyclonal antibody specifically detects SELENBP1 in WB. It exhibits reactivity toward Human, Mouse and Rat.

Quick Overview for SELENBP1 antibody (PE) (ABIN2179105)

Target: SELENBP1 (Selenium Binding Protein 1 (SELENBP1))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SELENBP1 antibody is conjugated to PE

Application: Western Blotting (WB)

Product Details anti-SELENBP1 Antibody (PE)

Cross-Reactivity: Human, Mouse, Rat

Predicted Reactivity: Dog,Cow,Rabbit

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human SBP1/Selenium Binding Protein 1

Isotype: IgG

Application Details

Application Notes: FCM: (1:20-100)
Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Target Details for SELENBP1

Target: SELENBP1 (Selenium Binding Protein 1 (SELENBP1))

Alternative Name: Selenium Binding Protein 1

Background:

Synonyms: SBP, SBP1, Selenbp2, Selenium binding protein 2, Selenium binding protein1, SELNBP1, SP56, 56 kDa selenium binding protein.

Background: Selenium is an essential trace element that confers tolerance to toxicity arising through exposure to heavy metals or other reactive xenobiotics. Selenium exhibits potent anticarcinogenic properties, and deficiency of selenium may cause certain neurologic diseases. Both effects are attributed to selenium-binding proteins. Selenium binding protein 1 is down-regulated in lung adenocarcinoma, colorectal cander and ovarian cancer. It is two-fold upregulated in the brains of patients suffering from schizophrenia, and is therefore a biomarker for this disease.

Gene ID: 1954

Pathways: Brown Fat Cell Differentiation